Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

STAAR Surgical Company

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

STAAR Surgical Company

Regulatory records
3
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 3 FDA records to the applicant name STAAR Surgical Company. 3 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Nov 14, 2025 to Mar 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MTA appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P030016, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 1911 Walker Ave., Monrovia, CA, 91016. Recorded on P030016/S051, decision dated Mar 4, 2026.

Changes described in PMA records

P030016/S051: The EVO/EVO+ Visian Implantable Collamer Lens (ICL)

FDA’s recorded scope: a software update to the optical metrology system used in the production of EVO/EVO+ Visian and Visian Toric Implantable Collamer Lenses to incorporate lens size and lens model identification inspection capabilities, in addition to the existing dioptric power and image quality measurement functions.

Mar 4, 2026 · 135 Review Track For 30-Day Notice

P030016/S049: Visian Toric Implantable Collamer Lens (TICL)

FDA’s recorded scope: Approval for updates to labeling for the Visian Toric Implantable Collamer Lens (TICL), EVO/EVO+ Visian ICL, and EVO/EVO+ Visian TICL to reflect the findings of the P030016/S001 PMA New Enrollment Post-Approval Study.

Dec 10, 2025 · Normal 180 Day Track No User Fee

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
STAAR Surgical CompanyPMA supplementMar 4, 2026FDA
STAAR Surgical CompanyPMA supplementDec 10, 2025FDA
STAAR Surgical CompanyPMA supplementNov 14, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.